Dr. Newell Washburn is an Associate Professor of Chemistry and Biomedical Engineering at Carnegie Mellon University, Pittsburgh. He is also President of Washburn Therapeutics, Inc., which develops gels for controlling inflammation and treating injuries and disease states. It offers biologically active gels that control inflammation by selectively neutralizing pro-inflammatory cytokines. Dr. Washburn received his Ph.D. from the University of California, Berkeley in Chemistry. Following post-doctoral research at the University of Minnesota in the Department of Chemical Engineering and Materials Science, he moved to the Polymers Division at the National Institute of Standards and Technology, first as a National Research Council Post-Doctoral Fellow then as Leader of the Biomaterials Group. During this time he was also an Adjunct Professor at Johns Hopkins University in the Graduate Program in Biotechnology.